<DOC>
	<DOCNO>NCT01783639</DOCNO>
	<brief_summary>The purpose study compare safety performance WIRION™ EPD patient undergo carotid artery stenting performance goal base analysis result previous US IDE carotid stenting embolic protection study</brief_summary>
	<brief_title>Safety Performance Evaluation WIRION™ EPD Patients Undergoing Carotid Artery Stenting</brief_title>
	<detailed_description>Patient registry procedure include : - Clinical Events Committee ( CEC ) ; responsibility validating report primary safety outcomes - Data Safety Monitoring Board ( DSMB ) ; review evaluate safety data include serious adverse event - 100 % data monitoring ; compare data enter registry - Source data verification ; ass accuracy , completeness registry data compare data external data source ( e.g. , medical record , paper electronic case report form ) . - Standard Operating Procedures ; address registry operation analysis activity , patient recruitment , data collection , data management , data analysis reporting adverse event . - Sample size assessment specify number participant follow duration . - Data Management Plan ; address situation variable report miss , unavailable , `` non-reported , '' uninterpretable , consider miss data inconsistency out-of-range result - Statistical analysis plan ; describe analytical principle statistical technique employ order address primary secondary objective , specify study protocol plan .</detailed_description>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>18 year age Anticipated patient life expectancy least 1 year Patient authorize representative , sign write Informed Consent form Patient willing comply protocol requirement Candidate catheterbased therapy single stenosis locate internal carotid artery ( ICA ) carotid bifurcation , suitable treatment single FDAapproved stent carotid use indication Reference vessel diameter intend filter location 3.5mm 6.0mm An adequate `` land zone '' least 30mm Patients severe symptomatic asymptomatic carotid artery stenosis , ≥ 50 % symptomatic patient OR ≥ 80 % asymptomatic patient At least one high surgical risk criterion , either anatomical comorbid risk factor , list : Category I Anatomical high risk factor Recurrent stenosis endarterectomy Previous radical neck surgery radiation therapy neck High cervical ICA lesion CCA lesion C2 clavicle Spinal immobility neck Tracheostomy tracheal stoma Any laryngeal nerve palsy bilateral carotid artery stenosis Category II Comorbid risk factor Contralateral carotid occlusion Unstable angina ( Canadian Cardiovascular Society class III/IV ) Congestive Heart Failure ( New York Heart Association functional class III/IV ) and/or know severe leave ventricular dysfunction LVEF &lt; 30 % Requires coronary artery bypass surgery , cardiac valve surgery , major vascular surgery , abdominal aortic aneurysm repair 3160 day post carotid stent procedure Recent MI ( &gt; 72 hr &lt; 4 week ) Severe pulmonary disease FEV1 &lt; 30 % CAD ≥2 unrevascularized vessel stenosis ≥70 % Age ≥75 year Uncontrolled diabetes Female patient child bear potential negative pregnancy test within previous 7 day agree remain birth control throughout study Total occlusion nearocclusion target vessel Severe lesion calcification Presence alternate source emboli Presence fill defect , angiographically visible thrombus , target site A great 50 % CCA lesion proximal target distal ( intracranial ) lesion severe target lesion Evolving , acute recent stroke within last 30 day Major stroke residual neurological deficit would confound neurologic assessment Vertebrobasilar insufficiency symptom Major operation 30 day index procedure Ipsilateral intracranial stenosis require treatment Any preexisting stent ipsilateral carotid artery , placement stent contralateral carotid within 30 day index procedure History intracranial hemorrhage within 12 month Any condition precludes proper angiographic assessment prevents femoral arterial access Uncontrolled hypertension Contraindication heparin bivalirudin , aspirin , thienopyridines Known sensitivity radiographic contrast medium control premedication History current indication bleed diathesis coagulopathy Chronic renal insufficiency Carotid artery dissection aortic arch anatomical anomaly Dementia neurological illness Patient enrol another drug device study protocol reach primary endpoint Severe pulmonary hypertension Intracranial pathology ( e.g. , tumor , AVM . aneurysm , etc ) would make study participation inappropriate confound neurologic assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Carotid</keyword>
	<keyword>Carotid artery stenting</keyword>
	<keyword>Stent</keyword>
	<keyword>Embolic protection</keyword>
	<keyword>Atherosclerotic Disease</keyword>
</DOC>